Skip to main content

Wegovy vs Zepbound

A side-by-side look at two weight management medications advertised on TV. Informational only — not medical advice.

Share

Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)

AttributeUS WegovyUS Zepbound
Generic namesemaglutide

Unverified catalogue summary (Generic name) for Wegovy in US; not checked against current local product information.

tirzepatide

Unverified catalogue summary (Generic name) for Zepbound in US; not checked against current local product information.

Drug classSee official local label

Unverified catalogue summary (Drug class) for Wegovy in US; not checked against current local product information.

See official local label

Unverified catalogue summary (Drug class) for Zepbound in US; not checked against current local product information.

TreatsChronic weight management, cardiovascular risk reduction

Unverified catalogue summary (Treats) for Wegovy in US; not checked against current local product information.

Chronic weight management, obstructive sleep apnea

Unverified catalogue summary (Treats) for Zepbound in US; not checked against current local product information.

CategoryWeight Management

Unverified catalogue summary (Category) for Wegovy in US; not checked against current local product information.

Weight Management

Unverified catalogue summary (Category) for Zepbound in US; not checked against current local product information.

ManufacturerNovo Nordisk

Unverified catalogue summary (Manufacturer) for Wegovy in US; not checked against current local product information.

Eli Lilly

Unverified catalogue summary (Manufacturer) for Zepbound in US; not checked against current local product information.

Year approved—

Unverified catalogue summary (Year approved) for Wegovy in US; not checked against current local product information.

—

Unverified catalogue summary (Year approved) for Zepbound in US; not checked against current local product information.

Catalogue warning levelSafety summary withheld — check official label

Unverified catalogue summary (Catalogue warning level) for Wegovy in US; not checked against current local product information.

Safety summary withheld — check official label

Unverified catalogue summary (Catalogue warning level) for Zepbound in US; not checked against current local product information.

Est. TV ad spend$380M$300M
Side effects and serious risks—

Unverified catalogue summary (Side effects and serious risks) for Wegovy in US; not checked against current local product information.

—

Unverified catalogue summary (Side effects and serious risks) for Zepbound in US; not checked against current local product information.

Sources and editorial standards

Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.

Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.

Frequently asked questions

Is Wegovy or Zepbound better?

This directory does not compare clinical effectiveness or safety. Listing Wegovy and Zepbound together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.

What's the difference between Wegovy and Zepbound?

The table shows catalogue identification and estimated advertising information for Wegovy and Zepbound, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.

Which one spends more on TV ads?

Wegovy has the larger estimated TV advertising budget of the two.